Supreme Completes First B2B Genetics Sale

JUNE 22, 2016 TORONTO, ONTARIO — (Marketwired) — 06/22/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) via its wholly owned subsidiary is pleased to announce it has completed its first sale of cannabis genetics to another Canadian Licensed Producer (the “LP”). Pursuant to the transaction, Supreme provided the LP with 6 strains for […]

Supreme Closes $3.6 Million Private Placement

JUNE 20, 2016 TORONTO, ONTARIO — (Marketwired) — 06/20/16 — Supreme Pharmaceuticals Inc. (the “Company”) (OTC PINK:SPRWF) (CSE:SL) is pleased to announce that it has closed the first tranche of a non-brokered private placement (the “Financing“) for gross proceeds of $3,615,880 Upon closing, the Company issued 9,039,700 units (each a “Unit“) at a price of $0.40 […]

Supreme Expands B2B Business Through Genetics Agreement

JUNE 06, 2016 TORONTO, ONTARIO — (Marketwired) — 06/06/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF )via its wholly owned subsidiary has entered into a letter of intent with a Canadian Licensed Producer (a “LP”) with respect to the long-term supply by the Company of multiple premium cannabis cultivars for production by the LP. […]

Supreme Secures Multiple Long-term Supply Agreements

MAY 20, 2016 TORONTO, ONTARIO — (Marketwired) — 05/20/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce that its wholly owned subsidiary AMMCan has entered into Letters of Intent (“LOIs”) with respect to the long-term supply of dried cannabis to five (5) Licensed Producers (as such term is defined in the Marihuana […]

Supreme Strengthens Board of Directors

APRIL 25, 2016 TORONTO, ONTARIO — (Marketwired) — 04/25/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL)(OTC PINK:SPRWF) is pleased to announce the strengthening of its Board of Directors, following receipt of the federal license to cultivate marijuana at its 7 acre (342,000 sq. ft.) hybrid greenhouse facility in Kincardine, Ontario. Michael La Brier joins […]

Supreme Establishes Strategic Alliance with Dinafem Seeds

APRIL 05, 2016 TORONTO, ONTARIO — (Marketwired) — 04/05/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL) (OTC PINK:SPRWF) is pleased to announce it has established a strategic alliance (the “Strategic Alliance”) with top international cannabis seed developer Dinafem Seeds (“Dinafem”) based in San Sebastian, Spain. Since 2002, Dinafem has been a global leader in the […]

Supreme Hosts Grand Opening of 7ACRE Hybrid Greenhouse Facility

MARCH 30, 2016 TORONTO, ONTARIO — (Marketwired) — 03/30/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (CSE:SL) (OTC PINK:SPRWF) is pleased to report that yesterday over 100 residents, vendors, media representatives, employees and local dignitaries attended a grand opening event at Supreme’s 7 Acre Hybrid Greenhouse in Kincardine, Ontario. Representatives of all levels of local government were […]

Supreme Closes Warrant Incentive Program

MARCH 18, 2016   TORONTO, ONTARIO — (Marketwired) — 03/18/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (OTC PINK:SPRWF) (CSE:SL) is pleased to announce the closing of the limited time incentive program (the “Incentive Program“), which commenced on February 16th, 2016. Pursuant to the Incentive Program, Supreme received aggregate proceeds of $1,013,654.22 through the issuance […]

Supreme Obtains MMPR License to Cultivate Medical Marijuana

MARCH 11, 2016 TORONTO, ONTARIO — (Marketwired) — 03/11/16 — Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (OTC PINK:SPRWF)(CSE:SL) is pleased to announce its wholly-owned subsidiary, Advanced Medical Marihuana Canada (“AMMCan“) has been granted a license to cultivate medical marijuana pursuant to the Marihuana for Medical Purposes Regulations (the “MMPR“). About Supreme Supreme is a Canadian publically traded company […]

Supreme Announces Closing of Warrant Incentive Program

JANUARY 08, 2016 January 8, 2016, Toronto, ON – Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (SPRWF – OTC) (“SL” – CSE) is pleased to announce the closing of the limited time incentive program (the “Incentive Program”), which commenced on December 7, 2015. Pursuant to the Incentive Program, Supreme received aggregate proceeds of $2,107,487.25 through the […]